行情

MDRX

MDRX

麦赛斯医药
NASDAQ

实时行情|Nasdaq Last Sale

13.73
-0.07
-0.51%
交易中 11:54 09/16 EDT
开盘
13.82
昨收
13.80
最高
13.85
最低
13.30
成交量
51.40万
成交额
--
52周最高
19.01
52周最低
7.55
市值
17.16亿
市盈率(TTM)
-29.0582
分时
5日
1月
3月
1年
5年
东方健康选择 Allscripts 医疗保健解决方案作为其合作伙伴之一,以进一步推动医疗保健创新
-Allscripts (NASDAQ:MDRX) is pleased to have been selected as one of Eastern Health’s innovation partners. As a result, Allscripts and Eastern Health have partnered to advance health-care services and
Allscripts (NASDAQ:MDRX) is pleased to have been selected as one of Eastern Health’s innovation partners. As a result, Allscripts and Eastern Health have partnered to advance health-care services and · 1天前
东方健康选择 Allscripts 作为其进一步医疗创新的合作伙伴之一
Allscripts (NASDAQ: MDRX) is pleased to have been selected as one of Eastern Health's innovation partners. As a result, Allscripts and Eastern Health have partnered to advance health-care services and programs while maximizing health system efficiencies an...
Business Wire · 1天前
这就是您现在应该保留 Allscripts (MDRX) 股票的原因
Zacks.com · 3天前
Allscripts Healthcare Solutions Inc (MDRX) 首席执行官 Paul Black 出售了 871,200 美元的股票
GuruFocus News · 5天前
内幕销售:Allscripts 医疗保健解决方案
MT Newswires · 09/08 17:10
Covid-19 刺激并购浪潮,并在 2020 年创下新高
The latest Enterprise Software M & A report from Hampleton Partners, the international technology mergers and acquisitions advisor, reveals that the number of deals targeting enterprise software assets has skyrocketed, with 836 deals recorded in the second...
MENAFN · 09/04 09:12
Allscripts Healthcare Solutions(纳斯达克股票代码:MDRX)可能难以分配资金
To avoid investing in a business that's in decline, there's a few financial metrics that can provide early indications...
Simply Wall St. · 09/01 13:52
调查 Allscripts Healthcare 的资本使用回报率
Pulled from Benzinga Pro data Allscripts Healthcare (NASDAQ:MDRX) posted a 22.23% decrease in earnings from Q1. Sales, however, increased by 1.44% over the previous quarter to $373.70 million.
Benzinga · 08/26 14:32
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解MDRX最新的财务预测,通过MDRX每股收益,每股净资产,每股现金流等数据分析麦赛斯医药近期的经营情况,然后做出明智的投资选择。
分析师评级

16位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测MDRX价格均价为17.86,最高价位21.00,最低价为16.00。
EPS
机构持股
总机构数: 353
机构持股: 1.45亿
持股比例: 115.66%
总股本: 1.25亿
类型机构数股数
增持
62
448.45万
建仓
23
66.25万
减持
100
1,003.10万
平仓
26
303.15万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
先进医疗设备和技术
-0.89%
医疗设备和用品
-0.68%
高管信息
Non-Executive Chairman/Independent Director
Michael Klayko
President/Chief Financial Officer/Chief Accounting Officer
Richard Poulton
Chief Executive Officer/Director
Paul Black
Executive Vice President
Lisa Khorey
Senior Vice President/General Counsel
Tejal Vakharia
Independent Director
Beth Altman
Independent Director
Mara Aspinall
Independent Director
P. Gregory Garrison
Independent Director
Jonathan Judge
Independent Director
Dave Stevens
Independent Director
David Stevens
Independent Director
Carol Zierhoffer
暂无数据
  • 全部
  • 财务报告
  • 内部人交易
更多
MDRX 简况
Allscripts Healthcare Solutions Inc是一家医疗保健信息技术解决方案提供商。它通过两个部门运营:核心临床和财务解决方案部门和数据、分析和护理协调部门。核心临床和财务解决方案部门从事患者参与、集成临床软件应用程序和财务管理解决方案,主要包括与电子病历相关的软件、财务和实践管理软件、相关的安装、支持和维护、外包、私有云托管和收入周期管理。数据、分析和护理协调部门从事护理协调、实际报销以及付款人和生命科学解决方案,主要针对医院、卫生系统、其他护理机构、付款人、生命科学公司和其他主要保健利益相关者。

微牛提供Allscripts Healthcare Solutions Inc(NASDAQ-MDRX)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的MDRX股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易MDRX股票基本功能。